아시아 태평양 지질 POCT 시장 – 2028년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

아시아 태평양 지질 POCT 시장 – 2028년까지의 산업 동향 및 예측

  • Healthcare
  • Published Report
  • May 2021
  • Asia-Pacific
  • 350 Pages
  • 테이블 수: 184
  • 그림 수: 34

아시아 태평양 지질 POCT 시장, 유형별(기구, 소모품 및 키트), 응용 분야별(고지혈증, 고중성지방혈증, 고지단백혈증, 가족성 고콜레스테롤혈증, 탕헤르 질환, 기타), 모드별(처방 기반 검사, OTC 기반 검사), 브랜드별(Roche Reflotron, Roche Cobas B 101, Alere Cholestech LDX, Alere Afinion, Samsung Labgeo, PTS Cardiochek, 기타), 플랫폼별(측면 유동 검사(면역 크로마토그래피 검사), 분자 진단, 면역 검사, 딥스틱, 마이크로유체), 최종 사용자별(병원, 전문 진단 센터, 홈 케어, 연구 실험실, 기타 최종 사용자), 유통 채널별(직접 입찰, 소매 판매), 국가별(일본, 중국, 한국, 인도, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀 및 아시아 태평양 지역) 산업 동향 및 예측 2028년까지

아시아 태평양 지질 POCT 시장시장 분석 및 통찰력: 아시아 태평양 지질 POCT 시장

지질 POCT 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 6.7%의 CAGR로 성장하고 있으며 2028년까지 2억 2,228만 달러에 도달할 것으로 예상된다고 분석했습니다. 만성 감염의 증가로 인해 사람들이 검사용 진료소 키트와 제품을 선택하게 되었고, 이로 인해 지질 POCT 시장이 성장할 것입니다.

POCT는 환자와 가까운 곳에서 수행할 수 있는 검사로 특징지어지며, 결과와 모니터링을 포함하여 즉시 의학적 결정을 내릴 수 있습니다. 지질 POCT는 지질의 환자 검사라고도 하며, 의사가 몇 시간이 아닌 몇 분 이내에 실시간 실험실 품질의 진단 결과를 정확하게 측정할 수 있도록 합니다.

새로운 생명공학적 발전은 엄청난 부스트 요인을 만들어내고 지질 POCT 시장의 성장을 촉진하고 있습니다. 높은 제품 비용은 지질 POCT 시장의 성장을 방해할 수 있습니다. 증가하는 의료 지출은 지질 POCT 시장의 성장에 기회로 작용할 것으로 예상됩니다. 실험실에서 얻은 검사 결과와의 불일치는 지질 POCT 시장에 엄청난 도전을 초래하고 있습니다.

지질 POCT 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 지질 POCT 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

아시아 태평양 지질 POCT 시장지질 POCT 시장 범위 및 시장 규모

The lipid POCT market is segmented into seven notable segments which are based on the type, application, mode, brand, platform, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the lipid POCT market is segmented into instruments, consumables and kits. In 2021, the instruments segment in the lipid POCT market is expected to grow due to changing lifestyles and increasing chronic diseases and a lack of awareness of over-the-counter POCT devices.
  • On the basis of application, the lipid POCT market is segmented into hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, tangier disease, familial hypercholesterolemia and others. In 2021, the hyperlipidemia segment in the lipid POCT market is expected to dominate because of the rising geriatric population and unhealthy lifestyle.
  • On the basis of mode, the lipid POCT market is segmented into OTC-based testing and prescription-based testing. In 2021, the prescription-based test segment in the lipid POCT market is expected to dominate because of high preference of point of care lipid testing been recommended for lipid profiling in hospitals and skilled laboratory professionals.
  • On the basis of brand, the lipid POCT market is segmented into roche reflotron, roche cobas B 101, alere cholestech LDX, alere afinion, samsung labgeo, PTS cardiochek and others. In 2021, the roche reflectron segment is expected to dominate in lipid POCT market due to their advanced technology over point of care devices.
  • On the basis of platform, the lipid POCT market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays. In 2021, the lateral flow assays (immunochromatography tests) segment in the lipid POCT market is expected to grow due to advanced technologies and inventions.
  • On the basis of end user, the lipid POCT market is segmented into hospitals, professional diagnostic centers, home care, research laboratories and other end users. In 2021, the hospitals segment in the lipid POCT market is expected to grow due to growing patient emphasis on diagnosis operations.
  • On the basis of distribution channel, the lipid POCT market is segmented into direct tender and retail sales. In 2021, direct tender segment in the lipid POCT market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.

Asia-Pacific Lipid POCT Market Country Level Analysis

Asia-Pacific lipid POCT market is analysed and market size information is provided by the country, type, application, mode, brand, platform, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific lipid POCT market report are the Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific.

China is going to dominate in the Asia-Pacific lipid POCT market because of the increasing diagnosis rate and awareness about the cardiovascular disease. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

New Product Launches by Manufacturers is Creating New Opportunities for Players in the Lipid POCT Market

The lipid POCT market also provides you with detailed market analysis for every country growth in aesthetic industry with lipid POCT market sales, impact of advancement in the lipid POCT market and changes in regulatory scenarios with their support for the lipid POCT market. The data is available for historic period 2011 to 2019. 

Competitive Landscape and Lipid POCT Market Share Analysis

The lipid POCT market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific lipid POCT market.

The major companies covered in the Asia-Pacific lipid POCT market report are Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., PTS Diagnostics, Trinity Biotech, AMD SOLUTIONS, Siemens Healthcare GmbH (a subsidiary of Siemens), TASCOM, General Life Biotechnology Co., Ltd., MICO BIOMED, Samsung Medison Co., Ltd., A. Menarini Diagnostics s.r.l, Nova Biomedical, Quest Diagnostics Incorporated, SKYLA CORPORATION among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the lipid POCT market.

For instance, 

  • In November 2020, SD Biosensor, INC. announced its partnership with DKSH Korea to develop pharmacy blood sugar business. This will help the company to diversify its market in coming years.

시장 참여자들의 협력, 합작투자 및 기타 전략은 지질 POCT 시장에서 회사 시장을 강화하고 있으며, 이를 통해 조직이 지질 POCT 시장에 대한 제공 사항을 개선하는 데에도 도움이 됩니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC LIPID POCT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 DISTRIBUTION CHANNEL LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

5.1.2 IMPROVING DIAGNOSIS SEEKING RATE

5.1.3 RISING TECHNOLOGICAL ADVANCEMENTS

5.1.4 RISING GERIATRIC POPULATION ACROSS THE GLOBE

5.1.5 RISING PREFERENCE FOR HOMECARE TESTING

5.2 RESTRAINTS

5.2.1 PRODUCT RECALLS

5.2.2 HIGH COSTS OF PRODUCTS

5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS

5.3 OPPORTUNITIES

5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS

5.3.2 RISING HEALTHCARE EXPENDITURE

5.3.3 PANDEMIC OUTBREAK OF COVID-19

5.3.4 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS

5.4 CHALLENGES

5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES

5.4.2 LACK OF ACCESSIBILITY

6 IMPACT OF COVID-19 ON THE ASIA-PACIFIC LIPID POCT MARKET

6.1 IMPACT ON PRICE

6.2 IMPACT ON DEMAND

6.3 IMPACT ON SUPPLY CHAIN

6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19

6.5 CONCLUSION:

1 ASIA-PACIFIC LIPID POCT MARKET, BY TYPE

1.1 OVERVIEW

1.2 INSTRUMENTS

1.2.1 ANALYZERS

1.2.1.1 PORTABLE

1.2.1.2 HANDHELD

1.2.1.3 STANDALONE

1.2.2 METER

1.2.3 BLOOD MONITORING DEVICE

1.2.4 OTHER POC PRODUCTS

1.3 CONSUMABLES AND KITS

1.3.1 CHOLESTEROL TEST KITS

1.3.2 STRIPS

1.3.3 ACCESSORIES

1.3.4 OTHERS

2 ASIA-PACIFIC LIPID POCT MARKET, BY APPLICATION

2.1 OVERVIEW

2.2 HYPERLIPIDEMIA

2.3 HYPERTRIGLYCERIDEMIA

2.4 HYPERLIPOPROTEINEMIA

2.5 FAMILIAL HYPERCHOLESTEROLEMIA

2.6 TANGIER DISEASE

2.7 OTHERS

3 ASIA-PACIFIC LIPID POCT MARKET, BY MODE

3.1 OVERVIEW

3.2 PRESCRIPTION-BASED TESTING

3.3 OTC-BASED TESTING

4 ASIA-PACIFIC LIPID POCT MARKET, BY BRAND

4.1 OVERVIEW

4.2 ROCHE REFLOTRON

4.3 ROCHE COBAS B 101

4.4 ALERE CHOLESTECH LDX

4.5 ALERE AFINION

4.6 PTS CARDIOCHEK

4.7 OTHERS

5 ASIA-PACIFIC LIPID POCT MARKET, BY PLATFORM

5.1 OVERVIEW

5.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS

5.3 MOLECULAR DIAGNOSTICS

5.4 IMMUNOASSAYS

5.5 DIPSTICKS

5.6 MICROFLUIDICS

6 ASIA-PACIFIC LIPID POCT MARKET, BY END USER

6.1 OVERVIEW

6.2 HOSPITALS

6.3 PROFESSIONAL DIAGNOSTIC CENTERS

6.3.1 CLINICAL LABORATORIES

6.3.2 OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS

6.4 HOME CARE

6.5 RESEARCH LABORATORIES

6.6 OTHER END USERS

7 ASIA-PACIFIC LIPID POCT MARKET, BY DISTRIBUTION CHANNEL

7.1 OVERVIEW

7.2 DIRECT TENDERS

7.3 RETAIL SALES

8 ASIA-PACIFIC LIPID POCT MARKET, BY REGION

8.1 ASIA-PACIFIC

8.1.1 JAPAN

8.1.2 CHINA

8.1.3 SOUTH KOREA

8.1.4 INDIA

8.1.5 AUSTRALIA

8.1.6 SINGAPORE

8.1.7 THAILAND

8.1.8 MALAYSIA

8.1.9 INDONESIA

8.1.10 PHILIPPINES

8.1.11 REST OF ASIA-PACIFIC

9 ASIA-PACIFIC LIPID POCT MARKET: COMPANY LANDSCAPE

9.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

10 SWOT ANALYSIS

11 COMPANY PROFILES

11.1 F. HOFFMANN-LA ROCHE LTD

11.1.1 COMPANY SNAPSHOT

11.1.2 REVENUE ANALYSIS

11.1.3 COMPANY SHARE ANALYSIS

11.1.4 PRODUCT PORTFOLIO

11.1.5 RECENT DEVELOPMENT

11.2 ABBOTT

11.2.1 COMPANY SNAPSHOT

11.2.2 REVENUE ANALYSIS

11.2.3 COMPANY SHARE ANALYSIS

11.2.4 PRODUCT PORTFOLIO

11.2.5 RECENT DEVELOPMENT

11.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS)

11.3.1 COMPANY SNAPSHOT

11.3.2 REVENUE ANALYSIS

11.3.3 COMPANY SHARE ANALYSIS

11.3.4 PRODUCT PORTFOLIO

11.3.5 RECENT DEVELOPMENTS

11.4 QUEST DIAGNOSTICS INCORPORATED

11.4.1 COMPANY SNAPSHOT

11.4.2 REVENUE ANALYSIS

11.4.3 COMPANY SHARE ANALYSIS

11.4.4 PRODUCT PORTFOLIO

11.4.5 RECENT DEVELOPMENTS

11.5 A. MENARINI DIAGNOSTICS S.R.L

11.5.1 COMPANY SNAPSHOT

11.5.2 COMPANY SHARE ANALYSIS

11.5.3 PRODUCT PORTFOLIO

11.5.4 RECENT DEVELOPMENT

11.6 ACON LABORATORIES, INC.

11.6.1 COMPANY SNAPSHOT

11.6.2 PRODUCT PORTFOLIO

11.6.3 RECENT DEVELOPMENT

11.7 AMD SOLUTIONS

11.7.1 COMPANY SNAPSHOT

11.7.2 PRODUCT PORTFOLIO

11.7.3 RECENT DEVELOPMENTS

11.8 CALLEGARI SRL

11.8.1 COMPANY SNAPSHOT

11.8.2 PRODUCT PORTFOLIO

11.8.3 RECENT DEVELOPMENTS

11.9 EUROMEDIX

11.9.1 COMPANY SNAPSHOT

11.9.2 PRODUCT PORTFOLIO

11.9.3 RECENT DEVELOPMENT

11.1 GENERAL LIFE BIOTECHNOLOGY CO., LTD.

11.10.1 COMPANY SNAPSHOT

11.10.2 PRODUCT PORTFOLIO

11.10.3 RECENT DEVELOPMENTS

11.11 JANT PHARMACAL CORPORATION

11.11.1 COMPANY SNAPSHOT

11.11.2 PRODUCT PORTFOLIO

11.11.3 RECENT DEVELOPMENT

11.12 MICO BIOMED

11.12.1 COMPANY SNAPSHOT

11.12.2 PRODUCT PORTFOLIO

11.12.3 RECENT DEVELOPMENTS

11.13 NOVA BIOMEDICAL

11.13.1 COMPANY SNAPSHOT

11.13.2 PRODUCT PORTFOLIO

11.13.3 RECENT DEVELOPMENTS

11.14 PRIMA LAB SA

11.14.1 COMPANY SNAPSHOT

11.14.2 PRODUCT PORTFOLIO

11.14.3 RECENT DEVELOPMENTS

11.15 PTS DIAGNOSTICS

11.15.1 COMPANY SNAPSHOT

11.15.2 PRODUCT PORTFOLIO

11.15.3 RECENT DEVELOPMENTS

11.16 SD BIOSENSOR, INC.

11.16.1 COMPANY SNAPSHOT

11.16.2 PRODUCT PORTFOLIO

11.16.3 RECENT DEVELOPMENTS

11.17 SKYLA CORPORATION

11.17.1 COMPANY SNAPSHOT

11.17.2 PRODUCT PORTFOLIO

11.17.3 RECENT DEVELOPMENTS

11.18 TASCOM

11.18.1 COMPANY SNAPSHOT

11.18.2 PRODUCT PORTFOLIO

11.18.3 RECENT DEVELOPMENT

11.19 TRINITY BIOTECH

11.19.1 COMPANY SNAPSHOT

11.19.2 REVENUE ANALYSIS

11.19.3 PRODUCT PORTFOLIO

11.19.4 RECENT DEVELOPMENTS

11.2 SAMSUNG MEDISON CO., LTD.

11.20.1 COMPANY SNAPSHOT

11.20.2 PRODUCT PORTFOLIO

11.20.3 RECENT DEVELOPMENT

12 QUESTIONNAIRE

13 RELATED REPORTS

표 목록

LIST OF TABLES

TABLE 1 BELOW MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID POCT DEVICES OFFERED BY DIFFERENT MANUFACTURERS:

TABLE 1 ASIA-PACIFIC LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 2 ASIA-PACIFIC INSTRUMENTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 ASIA-PACIFIC INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 4 ASIA-PACIFIC ANALYZERS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC CONSUMABLES & KITS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE , 2019-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC HYPERLIPIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC HYPERTRIGLYCERIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC HYPERLIPOPROTEINEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC TANGIER DISEASE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC LIPID POCT MARKET, BY MODE, 2019 – 2028, (USD MILLION)

TABLE 15 ASIA-PACIFIC PRESCRIPTION-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC OTC-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC ROCHE REFLOTRON IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC ROCHE COBAS B 101 IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC ALERE CHOLESTECH LDX IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC ALERE AFINION IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC PTS CARDIOCHEK IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC IMMUNOASSAYS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC DIPSTICKS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC MICROFLUIDICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC HOSPITALS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC HOME CARE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC RESEARCH LABORATORIES IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC OTHER END USERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC DIRECT TENDERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC RETAIL SALES IN LIPID POCT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC LIPID POCT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 42 ASIA-PACIFIC INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 44 ASIA-PACIFIC ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 45 ASIA-PACIFIC CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 ASIA-PACIFIC LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 ASIA-PACIFIC LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 48 ASIA-PACIFIC LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 49 ASIA-PACIFIC LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 50 ASIA-PACIFIC LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 51 ASIA-PACIFIC LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 ASIA-PACIFIC PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 ASIA-PACIFIC LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 JAPAN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 JAPAN INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 JAPAN ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 57 JAPAN ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 58 JAPAN CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 JAPAN LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 JAPAN LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 61 JAPAN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 62 JAPAN LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 63 JAPAN LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 64 JAPAN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 65 JAPAN PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 JAPAN LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 CHINA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 CHINA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 CHINA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 70 CHINA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 71 CHINA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 72 CHINA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 CHINA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 74 CHINA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 75 CHINA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 76 CHINA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 77 CHINA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 CHINA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 CHINA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 80 SOUTH KOREA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 SOUTH KOREA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 82 SOUTH KOREA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 83 SOUTH KOREA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 84 SOUTH KOREA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 85 SOUTH KOREA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 SOUTH KOREA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 87 SOUTH KOREA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 88 SOUTH KOREA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 89 SOUTH KOREA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 90 SOUTH KOREA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 91 SOUTH KOREA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 92 SOUTH KOREA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 93 INDIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 94 INDIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 95 INDIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 96 INDIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 97 INDIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 98 INDIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 99 INDIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 100 INDIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 101 INDIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 102 INDIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 103 INDIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 104 INDIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 105 INDIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 106 AUSTRALIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 107 AUSTRALIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 AUSTRALIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 109 AUSTRALIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 110 AUSTRALIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 111 AUSTRALIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 112 AUSTRALIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 113 AUSTRALIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 114 AUSTRALIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 115 AUSTRALIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 116 AUSTRALIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 117 AUSTRALIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 118 AUSTRALIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 119 SINGAPORE LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 SINGAPORE INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 121 SINGAPORE ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 122 SINGAPORE ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 123 SINGAPORE CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 124 SINGAPORE LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 125 SINGAPORE LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 126 SINGAPORE LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 127 SINGAPORE LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 128 SINGAPORE LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 129 SINGAPORE LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 130 SINGAPORE PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 131 SINGAPORE LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 132 THAILAND LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 133 THAILAND INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 134 THAILAND ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 135 THAILAND ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 136 THAILAND CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 137 THAILAND LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 138 THAILAND LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 139 THAILAND LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 140 THAILAND LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 141 THAILAND LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 142 THAILAND LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 143 THAILAND PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 144 THAILAND LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 145 MALAYSIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 146 MALAYSIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 147 MALAYSIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 148 MALAYSIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 149 MALAYSIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 150 MALAYSIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 151 MALAYSIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 152 MALAYSIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 153 MALAYSIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 154 MALAYSIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 155 MALAYSIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 156 MALAYSIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 157 MALAYSIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 158 INDONESIA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 159 INDONESIA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 160 INDONESIA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 161 INDONESIA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 162 INDONESIA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 163 INDONESIA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 164 INDONESIA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 165 INDONESIA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 166 INDONESIA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 167 INDONESIA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 168 INDONESIA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 169 INDONESIA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 170 INDONESIA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 171 PHILIPPINES LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 172 PHILIPPINES INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 173 PHILIPPINES ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 174 PHILIPPINES ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 175 PHILIPPINES CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 176 PHILIPPINES LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 177 PHILIPPINES LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 178 PHILIPPINES LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 179 PHILIPPINES LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 180 PHILIPPINES LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 181 PHILIPPINES LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 182 PHILIPPINES PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 183 PHILIPPINES LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 184 REST OF ASIA-PACIFIC LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

 

그림 목록

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC LIPID POCT MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC LIPID POCT MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC LIPID POCT MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC LIPID POCT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC LIPID POCT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC LIPID POCT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC LIPID POCT MARKET: MULTIVARIATE MODELLING

FIGURE 8 ASIA-PACIFIC LIPID POCT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC LIPID POCT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC LIPID POCT MARKET: SEGMENTATION

FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASE AND IMPROVING DIAGNOSIS SEEKING RATE ARE EXPECTED TO DRIVE THE ASIA-PACIFIC LIPID POCT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC LIPID POCT MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC LIPID POCT MARKET

FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT

FIGURE 15 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES IN 2016

FIGURE 1 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE, 2020

FIGURE 2 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 3 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 4 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 5 ASIA-PACIFIC LIPID POCT MARKET: BY APPLICATION, 2020

FIGURE 6 ASIA-PACIFIC LIPID POCT MARKET: BY APPLICATION, 2019-2028 (USD MILLION)

FIGURE 7 ASIA-PACIFIC LIPID POCT MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 8 ASIA-PACIFIC LIPID POCT MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 9 ASIA-PACIFIC LIPID POCT MARKET: BY MODE, 2020

FIGURE 10 ASIA-PACIFIC LIPID POCT MARKET: BY MODE, 2019-2028 (USD MILLION)

FIGURE 11 ASIA-PACIFIC LIPID POCT MARKET: BY MODE, CAGR (2021-2028)

FIGURE 12 ASIA-PACIFIC LIPID POCT MARKET: BY MODE, LIFELINE CURVE

FIGURE 13 ASIA-PACIFIC LIPID POCT MARKET: BY BRAND, 2020

FIGURE 14 ASIA-PACIFIC LIPID POCT MARKET: BY BRAND, 2020-2028 (USD MILLION)

FIGURE 15 ASIA-PACIFIC LIPID POCT MARKET: BY BRAND, CAGR (2021-2028)

FIGURE 16 ASIA-PACIFIC LIPID POCT MARKET: BY BRAND, LIFELINE CURVE

FIGURE 17 ASIA-PACIFIC LIPID POCT MARKET: BY PLATFORM, 2020

FIGURE 18 ASIA-PACIFIC LIPID POCT MARKET: BY PLATFORM, 2019-2028 (USD MILLION)

FIGURE 19 ASIA-PACIFIC LIPID POCT MARKET: BY PLATFORM, CAGR (2021-2028)

FIGURE 20 ASIA-PACIFIC LIPID POCT MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 21 ASIA-PACIFIC LIPID POCT MARKET: BY END USER, 2020

FIGURE 22 ASIA-PACIFIC LIPID POCT MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 23 ASIA-PACIFIC LIPID POCT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 24 ASIA-PACIFIC LIPID POCT MARKET: BY END USER, LIFELINE CURVE

FIGURE 25 ASIA-PACIFIC LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 26 ASIA-PACIFIC LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

FIGURE 27 ASIA-PACIFIC LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 28 ASIA-PACIFIC LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC LIPID POCT MARKET: SNAPSHOT (2020)

FIGURE 30 ASIA-PACIFIC LIPID POCT MARKET: BY COUNTRY (2020)

FIGURE 31 ASIA-PACIFIC LIPID POCT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 32 ASIA-PACIFIC LIPID POCT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 33 ASIA-PACIFIC LIPID POCT MARKET: BY TYPE (2021-2028)

FIGURE 34 ASIA-PACIFIC LIPID POCT MARKET: COMPANY SHARE 2020 (%)

 

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

Asia-Pacific Lipid POCT Market to grow at a CAGR of 6.7% by forecast 2029.
Asia-Pacific Lipid POCT Market value to reach USD 222.28 million by forecast 2028.
The major companies covered in the Asia-Pacific lipid POCT market report are Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., PTS Diagnostics, Trinity Biotech, AMD SOLUTIONS, Siemens Healthcare GmbH (a subsidiary of Siemens), TASCOM, General Life Biotechnology Co., Ltd., MICO BIOMED, Samsung Medison Co., Ltd., A. Menarini Diagnostics s.r.l, Nova Biomedical, Quest Diagnostics Incorporated, SKYLA CORPORATION.
The countries covered in the Asia-Pacific lipid POCT market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and the rest of Asia-Pacific.